fibrodysplasia

Clementia jumps on NDA plans for unmet rare bone disease
BioCentury
Wed, 10/24/18 - 11:44 pm
Clementia Pharmaceuticals
FOP
palovarotene
fibrodysplasia
Blueprint Medicines unveils preclinical data for rare bone disease program
BioCentury
Sun, 09/30/18 - 03:30 pm
Blueprint Medicines
BLU-782
fibrodysplasia